CIK 0001583648 · Non-accelerated filer<br>Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 300784346
- Phone
- (484) 253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,725,861
- in 7 filings, $11.7M under 10b5-1 plans
Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-12 | JENKINS GEORGE M Director | Sale 10b5-1 | −3,335 | $134.21 | $448K | 149,228 |
| 2026-10-12 | JENKINS GEORGE M Director | Sale 10b5-1 | −1,447 | $135.50 | $196K | 147,781 |
| 2026-10-12 | JENKINS GEORGE M Director | Sale 10b5-1 | −817 | $136.44 | $111K | 146,964 |
| 2026-09-16 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,154 | $7.14 | $15K | 2,154 |
| 2026-09-16 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,148 | $9.08 | $20K | 4,302 |
| 2026-09-16 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −1,659 | $151.16 | $251K | 2,643 |
| 2026-09-16 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −989 | $152.36 | $151K | 1,654 |
| 2026-09-16 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −1,654 | $153.24 | $253K | 0 |
| 2026-09-16 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,154 | 2,165 | ||
| 2026-09-16 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,148 | 2,148 | ||
| 2026-09-15 | JENKINS GEORGE M Director | Sale 10b5-1 | −954 | $149.38 | $143K | 160,939 |
| 2026-09-15 | JENKINS GEORGE M Director | Sale 10b5-1 | −263 | $150.40 | $40K | 160,676 |
| 2026-09-15 | JENKINS GEORGE M Director | Sale 10b5-1 | −560 | $151.33 | $85K | 160,116 |
| 2026-09-14 | JENKINS GEORGE M Director | Sale 10b5-1 | −5,632 | $151.46 | $853K | 169,613 |
| 2026-09-14 | JENKINS GEORGE M Director | Sale 10b5-1 | −6,160 | $152.12 | $937K | 163,453 |
| 2026-09-14 | JENKINS GEORGE M Director | Sale 10b5-1 | −1,560 | $153.10 | $239K | 161,893 |
| 2026-09-11 | JENKINS GEORGE M Director | Sale 10b5-1 | −6,520 | $150.62 | $982K | 181,096 |
| 2026-09-11 | JENKINS GEORGE M Director | Sale 10b5-1 | −4,577 | $151.72 | $694K | 176,519 |
| 2026-09-11 | JENKINS GEORGE M Director | Sale 10b5-1 | −1,274 | $153.06 | $195K | 175,245 |
| 2026-09-02 | KIRITSY CHRISTOPHER P Director | Option exercise | +313 | $127.20 | $40K | 563 |
Page 3 of 12 · 232 trades